Największe oszustwo medyczne?! Zatajają prawdę o cholesterolu, by wypisywać recepty! Hubert Czerniak

The speaker uses the potato as an example of a food with a very high glycemic index, meaning it causes a sharp, rapid rise in glucose followed by a quick fall—exactly the pattern he says drives metabolic damage. He then offers a practical hack: cooking and then cooling the potato overnight alters its starch structure to form resistant starch, which is less digestible and results in a lower, slower glucose response. Reheating the next morning preserves this benefit. This small behavioral change, he suggests, makes the potato 'more healthy'. It’s a simple biohack for starch lovers.

Homocysteine is a central node in the speaker's argument. He explains it's an amino acid that should be converted to cystathionine, but that requires B6, B9 (folate), and B12. Deficiencies are widespread, and the conventional use of folic acid is ineffective for those with MTHFR mutations. He also mentions a specific enzyme defect in beta-synthase where the enzyme is genetically insensitive to B6; in such cases, administering very high doses of B6 can override the insensitivity in roughly half of cases, while the other half cannot be rescued. The takeaway is a layered protocol: check B12/folate levels (using optimal ranges), ensure active forms are used, and consider high-dose B6 if standard support fails. This addresses the root cause instead of covering it up by lowering cholesterol.

In the closing minutes, the speaker identifies vitamin B3 as the best agent to lower cholesterol. He distinguishes between the two common forms: niacinamide (amid) and nicotinic acid (kwas nikotynowy). Niacinamide has applications in degenerative joint disease, rheumatoid arthritis, Alzheimer’s, and schizophrenia, but for lipid and atherosclerotic effects, only nicotinic acid works. He recommends doses of half a gram to a full gram up to 3000 mg daily, presenting it as the simplest solution—knowledge patients can take to their doctor and achieve satisfaction on both sides. This protocol is positioned as the direct alternative to statin therapy, aligning with his overall narrative that we should support the body’s physiology rather than block it.

The speaker directly ties statin action to heavy metal metabolism. He argues that evolution has programmed a response: when heavy metals invade, the HMG-CoA reductase enzyme is upregulated to produce cholesterol, which then traps the metals in fat cells. Blocking this enzyme with statins—or with red yeast rice, which he correctly notes contains a natural statin—undermines this detox strategy. He warns of the consequences: memory impairment, cancers, diabetes, psychosis, depression, organ failure, and infertility. He extends this to red yeast rice, advising listeners who ask about it not to use it because it acts just like a statin. This negative protocol is a corollary of his detox theory.

The speaker recounts his own experience as an intern hearing a cardiology professor (Prof. Markiewicz, PSK4) say that heart attack patients with cholesterol above 350 mg/dL significantly more often survive. He notes that in the past, postmenopausal women with cholesterol around 350–500 mg/dL were considered normal; they had no vasomotor symptoms (hot flashes, palpitations) and fewer heart attacks than women with lower levels. He frames cholesterol as the body's homeostatic defense against 'the stupidity of food, lifestyle, stress'—something the body raises to protect itself, not a pathology. The current advice to lower cholesterol across the board ignores this protective role.

He explicitly states that the most important factor raising cholesterol is a high-carbohydrate diet, not a high-fat diet. He references studies using radioactive carbon isotopes that showed the carbon present in fats does not end up in cholesterol or arterial fatty deposits; instead, it is the carbon from ingested carbohydrates that forms these lipids. He provides a long list of culprits: groats, rice, flours, Jerusalem artichoke, sweet potatoes, potatoes, dumplings, pasta, rolls, pancakes, bread. He also mentions alcohol as a carbohydrate. He contrasts this with the recommendation for a low-carbohydrate diet, pointing to the website of the Rodzeń brothers as a resource. This reframing suggests that the entire nutritional foundation of cholesterol management is misguided.

The speaker explains that homocysteine, an amino acid, damages the inner lining of arteries (endothelium). If that damage were left unchecked, it would lead to clots and blockages. The liver then dispatches LDL particles—which he describes as elastic, smooth, and resilient—to adhere to the injured wall and seal it off, preventing thrombus formation. He calls LDL 'our rescue, our medicine.' Consequently, artificially lowering cholesterol when the root cause (high homocysteine) remains would strip away this protective layer and increase risk. The proper intervention is to address the homocysteine elevation itself, typically by correcting deficiencies in vitamins B6, B9, and B12.

According to the speaker, until recently the accepted B12 range was 300–1200 pg/mL. In the last year, that lower bound was dropped to 170 pg/mL and the upper bound to 600. He argues that symptoms of serious mental and neurological disturbance—anxiety, depression, psychoses, suicidal thoughts—reliably appear when levels fall below 600 pg/mL. By capping the normal range at 600, the medical system labels many symptomatic people as having adequate B12. He and others believe that the optimal, truly healthy range is 600–1200 pg/mL. This knowledge gap also affects young doctors who accept the lab slip uncritically.